Chemical Industry FDA Approves Teva’s Weltruza: A Paradigm Shift in Schizophrenia Management and Long-Acting Injectables WASHINGTON — In a milestone decision for neuropsychiatric care, the US Food and Drug Administration… Nana WuOctober 12, 2026
